BNGO · CIK 0001411690 · operating
Bionano Genomics, Inc. (BNGO) is a laboratory analytical instruments company incorporated in DE, listed on the Nasdaq. With a market capitalization of $12 million, Bionano Genomics, Inc. is a micro-cap company. The stock currently trades at $1.09, down 3.93% today, with a 52-week range of $1.06–$5.50.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-88.13 | $-88.13 | -1194.1% | |
| 2023 | $-6.81 | $-6.81 | -1380.4% | |
| 2022 | $-0.46 | $-0.46 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001411690-25-000037 | SEC ↗ |
| 2023-12-31 | 2024-03-05 | 0001411690-24-000013 | SEC ↗ |
| 2022-12-31 | 2023-03-09 | 0001411690-23-000010 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0001411690-22-000007 | SEC ↗ |
| 2020-12-31 | 2021-03-23 | 0001411690-21-000004 | SEC ↗ |
| 2019-12-31 | 2020-03-10 | 0001411690-20-000006 | SEC ↗ |
| 2018-12-31 | 2019-03-14 | 0001628280-19-002959 | SEC ↗ |